These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 2691691)

  • 1. Lipoproteins and coronary heart disease.
    Betteridge DJ
    J Hum Hypertens; 1989 Dec; 3 Suppl 2():13-24; discussion 24-5. PubMed ID: 2691691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetic dyslipidemia and atherosclerosis.
    Shepherd J
    Schweiz Med Wochenschr; 1994 Nov; 124(44):1933-7. PubMed ID: 7973520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum lipoproteins and ischemic vascular disease: on the interpretation of serum lipid versus serum lipoprotein concentrations.
    Rössner S
    J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S201-5. PubMed ID: 6177957
    [No Abstract]   [Full Text] [Related]  

  • 4. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy.
    Oki JC
    Pharmacotherapy; 1995; 15(3):317-37. PubMed ID: 7667166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoproteins and coronary heart disease.
    Krauss RM
    Postgrad Med; 1989 Apr; Spec No():54-8; discussion 89-90. PubMed ID: 2726627
    [No Abstract]   [Full Text] [Related]  

  • 6. High-density lipoprotein cholesterol and triglycerides as therapeutic targets for preventing and treating coronary artery disease.
    Gotto AM
    Am Heart J; 2002 Dec; 144(6 Suppl):S33-42. PubMed ID: 12486414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid measurements for coronary risk assessment: a review.
    Berg LH
    Am J Med Technol; 1981 Jul; 47(7):539-43. PubMed ID: 7025628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of hypercholesterolaemia in the patient with diabetes.
    Packard C; Olsson AG
    Int J Clin Pract Suppl; 2002 Jul; (130):27-32. PubMed ID: 12296606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic treatment of type 2 diabetic dyslipidemia.
    Moon YS; Kashyap ML
    Pharmacotherapy; 2004 Dec; 24(12):1692-713. PubMed ID: 15585439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The emerging problem of plasma lipid changes during antihypertensive therapy.
    Johnson BF
    J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S213-21. PubMed ID: 6177959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of oral contraceptives on lipid metabolism.
    Krauss RM
    J Reprod Med; 1986 Jun; 31(6 Suppl):549-50. PubMed ID: 3723487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid--a position paper developed by the European Consensus Panel on HDL-C.
    Chapman MJ; Assmann G; Fruchart JC; Shepherd J; Sirtori C;
    Curr Med Res Opin; 2004 Aug; 20(8):1253-68. PubMed ID: 15324528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoproteins and heart disease.
    McCance KL
    Nurse Pract; 1983 May; 8(5):68-9, 72. PubMed ID: 6866345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atherosclerotic risk factors in cardiovascular disease.
    LaRosa JC
    J Reprod Med; 1986 Sep; 31(9 Suppl):906-12. PubMed ID: 3772910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The emergence of triglycerides as a significant independent risk factor in coronary artery disease.
    Assmann G; Schulte H; Funke H; von Eckardstein A
    Eur Heart J; 1998 Oct; 19 Suppl M():M8-14. PubMed ID: 9821011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The contribution of lipids to coronary heart disease in diabetes mellitus.
    Stewart MW; Laker MF; Alberti KG
    J Intern Med Suppl; 1994; 736():41-6. PubMed ID: 7986307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physical activity and plasma lipids.
    Høstmark AT
    Scand J Soc Med Suppl; 1982; 29():83-91. PubMed ID: 6982509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Choice and use of blood lipid tests. An epidemiologic perspective.
    Hulley SB; Lo B
    Arch Intern Med; 1983 Apr; 143(4):667-73. PubMed ID: 6340621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive therapy and lipids. Evidence, mechanisms, and implications.
    Weinberger MH
    Arch Intern Med; 1985 Jun; 145(6):1102-5. PubMed ID: 2860883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of modifying triglycerides and triglyceride-rich lipoproteins on cardiovascular outcomes.
    Abdel-Maksoud M; Sazonov V; Gutkin SW; Hokanson JE
    J Cardiovasc Pharmacol; 2008 Apr; 51(4):331-51. PubMed ID: 18427276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.